

12 Jan 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/artbio-announces-dosing-of-two-cohorts-with-ab001-in-artisan-a-phase-1-alpha-radioligand-therapy-clinical-trial-for-metastatic-castration-resistant-prostate-cancer-302657972.html

09 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/artbio-announces-fda-clearance-of-ind-application-for-lead-alpha-radioligand-therapy-ab001-302549360.html